Workup for Cannabinoid Hyperemesis Syndrome
The workup for suspected CHS is primarily clinical and based on diagnostic criteria rather than laboratory testing—focus on obtaining a detailed cannabis use history and ruling out life-threatening conditions, particularly in the emergency setting. 1
Clinical Diagnostic Approach
Essential History Elements
The diagnosis hinges on three key clinical criteria 1:
1. Clinical Features:
- Stereotypical episodic vomiting resembling cyclic vomiting syndrome
- Frequency: ≥3 episodes annually
- Associated with nausea and abdominal pain
- Pathognomonic feature: Relief with prolonged hot baths or showers (reported in 71% of cases, though not exclusive to CHS)
2. Cannabis Use Pattern:
- Duration: >1 year of use before symptom onset
- Frequency: >4 times per week on average
- Most patients (68%) use daily, with many using 6+ times daily 2
- Mean duration before symptom onset: 6.6 years 1
3. Cannabis Cessation Response:
- Symptom resolution after ≥6 months of complete abstinence, OR
- Resolution equal to the duration of 3 typical vomiting cycles
Critical Differential Diagnosis Workup
In the Emergency Department, you must immediately exclude life-threatening conditions 1:
- Acute abdomen
- Bowel obstruction
- Mesenteric ischemia
- Pancreatitis
- Myocardial infarction
In the Outpatient Setting, after excluding structural abnormalities, consider 1:
- Rumination syndrome
- Gastroparesis
- Cyclic vomiting syndrome (non-cannabis related)
- Pregnancy
- Migraine-associated vomiting
- Functional chronic nausea and vomiting syndrome
Laboratory and Imaging Considerations
Urinary Cannabis Metabolite Testing
Urinary THC-COOH levels >100 ng/mL strongly support the diagnosis and indicate significant chronic cannabis exposure 3. In a pediatric series, 14 of 15 CHS patients had levels >100 ng/mL (P<0.0005), with 7 exceeding 500 ng/mL. This testing can:
- Guide diagnostic evaluation
- Reduce unnecessary workup
- Provide objective evidence when patient history is unclear
Important caveat: One patient with levels <100 ng/mL had abstained for 2 weeks, demonstrating that timing matters. Most patients with elevated levels had used cannabis within 2 days of testing 3.
Structural Evaluation
The extent of imaging and endoscopy should be guided by:
- Presence of alarm features
- Atypical presentation
- Failure to meet diagnostic criteria
- Need to exclude competing diagnoses
Avoid extensive, repeated evaluations once CHS is diagnosed, as patients often undergo unnecessary procedures when the diagnosis is missed 4.
Algorithmic Approach to Diagnosis
Step 1: Obtain detailed cannabis history
- Duration of use (look for >1 year)
- Frequency (look for >4x/week, especially daily use)
- Product type (smoking/vaping most common) 2
- Age of onset (average patient is 30 years old, 69% male) 1
Step 2: Characterize vomiting pattern
- Episodic vs continuous
- Frequency (≥3 episodes/year required)
- Associated hot water bathing behavior
- Symptom-free intervals between episodes
Step 3: Rule out emergent conditions
- Based on clinical presentation and risk factors
- Targeted imaging/labs as indicated
Step 4: Consider urinary THC-COOH testing
- Particularly useful when diagnosis uncertain
- Levels >100 ng/mL strongly supportive 3
Step 5: Assess for psychiatric comorbidity
- Anxiety and depression are very common 1
- Concurrent substance use disorders
- May require co-management with psychiatry 1
Common Pitfalls to Avoid
Overlooking the diagnosis in patients with recurrent ED visits for vomiting—CHS is increasingly common with cannabis legalization 1
Accepting patient self-diagnosis of "food poisoning" or stress—many patients remain uncertain about cannabis's role despite diagnosis 1
Failing to specify cessation duration—counsel patients that minimum 3 months of complete abstinence is needed to confirm diagnosis and achieve symptom relief 5
Extensive repeated workups—once diagnosed, avoid unnecessary imaging and procedures 4
Not screening for cannabinoid withdrawal syndrome—47% prevalence in cannabis users, can complicate the clinical picture 1
Documentation and Patient Education
When CHS is suspected, document:
- Specific cannabis use patterns (frequency, duration, product type)
- Hot water bathing behavior
- Previous episodes and their resolution
- Response to cannabis cessation (if any prior attempts)
- Concurrent psychiatric conditions and substance use
Educate patients explicitly that cannabis cessation for at least 3-6 months is the only definitive treatment and necessary to confirm the diagnosis 1, 5.